Our findings that MUC1 significantly associates with MYC and NOTCH2 in SCLC tumors further indicate that MUC1-C may be a potential target for inhibiting CSC self-renewal in the treatment of NE and non-NE SCLCs. The gene discussed is MYC; the disease is small cell lung carcinoma.